Valerie Barnett serves as Executive at Cytek Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Valerie Barnett has executed 57 insider transactions totaling $32.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 18, 2022 involved selling 786 shares valued at $11.6K.
Valerie Barnett currently holds 116,462 shares of Cytek Biosciences, Inc. (CTKB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Valerie Barnett has been a net buyer of CTKB stock. They have purchased $32.3K and sold $0 worth of shares.
Valerie Barnett's most recent insider trade was on Nov 18, 2022, when they sold 786 shares at $14.75 per share.
Get notified when new Form 4 filings are submitted
| $14.06 |
| Discretionary |
| Aug 18, 2022 | CTKB | $0 | Option Exercise | 2,016 | $N/A | Discretionary |
| May 18, 2022 | CTKB | $0 | Option Exercise | 2,688 | $N/A | Discretionary |
| May 18, 2022 | CTKB | $10.1K | Payment | 1,047 | $9.65 | Discretionary |
| Mar 4, 2022 | CTKB | $49.5K | Option Exercise | 10,500 | $4.71 | Discretionary |
| Jul 22, 2021 | CTKB | $32.3K | Purchase | 1,900 | $17.00 | Discretionary |